Press release
Celiac Disease Market Know the Scope and Trends
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn by 2031, exhibiting a CAGR of 9.8% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2874
Celiac disease is a chronic autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. Upon gluten consumption, the immune system initiates a response that damages the small intestine's lining, leading to the destruction of intestinal villi. This impairment significantly reduces the body's ability to absorb essential nutrients-such as proteins, carbohydrates, lipids, vitamins, and minerals-potentially resulting in malnutrition and other long-term health complications.
The Celiac Disease Market is witnessing substantial growth, driven by increasing disease prevalence, advancements in diagnostic technologies, and rising consumer awareness. Key trends shaping the market include improved diagnosis rates, expansion of the gluten-free product sector, and ongoing research into therapeutic interventions. The market is further propelled by the growing demand for gluten-free dietary alternatives and continuous innovations in disease management solutions.
List of Prominent Players in the Celiac Disease Market:
• Amgen
• Anokion SA
• BioLineRx Ltd
• ChemoCentryx, Inc
• COUR Pharmaceutical
• F. Hoffmann-La Roche Ltd
• ImmunogenX, LLC
• Innovate Biopharmaceuticals
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
Market Dynamics
Drivers:
The growth of the Celiac Disease Market is primarily driven by several key factors. The rising prevalence of celiac disease has significantly increased the demand for gluten-free products and therapeutic solutions. Additionally, heightened consumer awareness regarding the health risks associated with gluten consumption has contributed to market expansion. While many individuals receive a formal celiac disease diagnosis, an increasing number of undiagnosed individuals are adopting gluten-free diets due to growing awareness of gluten-related health concerns. Furthermore, advancements in diagnostic technologies are enabling earlier and more accurate detection, leading to a larger diagnosed patient population.
Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2874
Challenges:
Despite its promising growth trajectory, the Celiac Disease Market faces several obstacles. The high cost of gluten-free products presents a financial barrier, restricting access for many patients and their families. Additionally, underdiagnosis remains prevalent, particularly in regions with limited awareness and inadequate knowledge about the disease.
Regional Trends:
North America holds a leading position in the celiac disease treatment market, supported by a high prevalence of the disease, well-established market players, and substantial healthcare spending. The United States remains the largest contributor to regional market growth, driven by strong consumer demand and robust healthcare infrastructure.
Meanwhile, the Asia-Pacific region is projected to witness rapid growth over the forecast period (2023-2032), fueled by increasing disease awareness and expanding population demographics. Within the region, China holds the largest market share, while India is emerging as the fastest-growing market for celiac disease treatments and gluten-free products.
Recent Developments:
• In June 2021, BioLineRx announced the start of a Phase 2b clinical trial for its flagship drug, BL-7010, as a therapy for celiac disease. The experiment will assess the safety and efficacy of BL-7010 in lowering gluten-induced symptoms and gut inflammation in celiac disease patients.
• In September 2022, ChemoCentryx recently announced encouraging results from a Phase 2 clinical trial of a new medication candidate for celiac disease-associated refractory sprue. The study found that refractory sprue, a severe form of celiac disease, showed encouraging results in terms of symptom reduction and intestinal health.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2874
Segmentation of Celiac Disease Market-
By Treatments-
• Infliximab
• Larazotide Acetate
• Gluten-Free Diet
• Others
By Route of Administration-
• Oral
• Parenteral
By End-Users-
• Hospitals
• Homecare
• Others
By Distribution Channels-
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information:
https://www.insightaceanalytic.com/report/celiac-disease-market/2874
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Celiac Disease Market Know the Scope and Trends here
News-ID: 4171762 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Immune-Mediated Inflammatory Diseases Market Exclusive Report with Detailed Stud …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Immune-Mediated Inflammatory Diseases Market - (By Treatment Type (Traditional Drugs, Biologic Therapies, Novel Therapies), Indication (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), Inflammatory Bowel Disease (IBD), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Psoriasis, Others), By Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)), Trends, Industry…
Green Technology and Sustainability Market Exclusive Report on the Latest Revenu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Green Technology and Sustainability Market"-, By Component (Solutions & Services), By Deployment (Cloud & On-Premise), By Enterprise Type (Large Enterprise and SMEs), By Implemented Technology (Internet of Things, AI & Analytics, Digital Twin, Cloud Computing, Blockchain), By Application (Air & Water Pollution Monitoring, Carbon Footprint Management, Crop Monitoring, Fire Detection, Forest Monitoring, Green Building, Soil Condition…
Electric Powertrain Market Report Latest Trends and Future Opportunities Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Electric Powertrain Market"-, By Integration Type (Integrated & Non-integrated), Component (Motor, Battery, BMS, Controller, PDM, Inverter/Converter, On-Board Charger), Propulsion (BEV, PHEV), Vehicle Type (PC & LCV), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031."
The Electric Powertrain Market is estimated to reach over USD 301.6 billion by 2031, exhibiting a CAGR of 17.1%…
One Step RT-qPCR Kits Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " One Step RT-qPCR Kits Market - (By Reaction (25 Rxn one step RT-qPCR kits, 50 Rxn one step RT-qPCR kits, 100 Rxn one step RT-qPCR kits, 200 Rxn one step RT-qPCR kits, 400 Rxn one step RT-qPCR kits, 500 Rxn one step RT-qPCR kits, 1000 Rxn one step RT-qPCR kits, and above 1000 Rxn one-step…
More Releases for Celiac
Celiac Disease Market Emerging Trends and Growth Prospects 2034
Introduction
Celiac disease is a chronic autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals, leading to intestinal damage, malabsorption, and systemic complications. Affecting approximately 1% of the global population, the disease remains underdiagnosed, with many patients suffering from undiagnosed or mismanaged symptoms such as abdominal pain, diarrhea, anemia, osteoporosis, and neurological issues.
The cornerstone of treatment for decades has been the lifelong gluten-free diet (GFD), which requires strict avoidance of…
Celiac Disease Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn…
Celiac Disease Treatment Market
Celiac disease is an autoimmune disorder that affects the small intestine, triggered by the ingestion of gluten-a protein found in wheat, barley, and rye. This condition leads to inflammation and damage in the intestinal lining, which can hinder nutrient absorption and result in various gastrointestinal and systemic symptoms. As awareness of celiac disease grows, so does the demand for effective treatments and dietary solutions. This post delves into the celiac…
Celiac Disease Drugs Market to Record an Exponential CAGR
Celiac Disease Drugs Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Celiac Disease Drugs market recent progressions. The Celiac Disease Drugs market report is prepared after fundamental levels of research regarding the Celiac Disease Drugs Industry.
Celiac Disease Drugs Market by Drugs (First Line of Treatment and Second Line of Treatment) - Global Opportunity Analysis…
Celiac disease Market to Observe Strong Development by 2025
The global Celiac Disease Market is prophesied to rake in a heavy demand on account of three decisive factors such as healthy government initiatives, prevalence of the disease, and increased consumption of foods containing gluten.
Governments of different countries such as the U.K., Canada, New Zealand, Australia, and Argentina and the European Union are expected to accelerative initiatives for the treatment of celiac disease. These governments could provide a strong boost…
Celiac disease market: Global Trends and Forecast Analysis 2025
Celiac disease is an autoimmune disorder in which the surface of the small intestine is damaged by a protein called gluten. Gluten is found in rye, barley, and wheat. Gluten triggers an immune reaction in the small intestine damaging the villi (small finger-like projections in the small intestine which promote absorption). The damage restricts the ability of the body to absorb proteins, nutrients, fats, vitamins, carbohydrates, and minerals. Eventually, this…
